|
|
angiogenesis
|
GO:0001525 |
201 |
0.430
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.424
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.360
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.344
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.327
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.280
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.275
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.258
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.254
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.212
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.200
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.197
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.197
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.195
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.191
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.179
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.179
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.178
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.175
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.169
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.166
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.160
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.155
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.146
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.146
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.145
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.145
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.142
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.133
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.133
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.130
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.128
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.126
|
Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.123
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.122
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.116
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.116
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.115
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.104
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.103
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.101
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.101
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.097
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.097
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.097
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.097
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.096
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.095
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.093
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.091
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.089
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.088
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.087
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.086
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.083
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.083
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.083
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.082
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.082
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.081
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.077
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.077
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.077
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.076
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.075
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.074
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.074
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.073
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.073
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.072
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.072
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.070
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.070
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.069
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.069
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.068
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.067
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.067
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.066
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.064
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.064
|
Mouse |
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.064
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.064
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.063
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.063
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.062
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.062
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.062
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.062
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.061
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.061
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.061
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.061
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.061
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.059
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.058
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.056
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.056
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.056
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.055
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.054
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.052
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.052
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.052
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.052
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.051
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.050
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.050
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.050
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.050
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.050
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.049
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.049
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.049
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.048
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.048
|
Mouse |
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.047
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.047
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.047
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.047
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.047
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.046
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.046
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.046
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.046
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.046
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.045
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.045
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.045
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.045
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.044
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.044
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.044
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.044
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.044
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.044
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.044
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.043
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.043
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.043
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.043
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.042
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.042
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.042
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.042
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.041
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.041
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.041
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.041
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.040
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.040
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.040
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.040
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.039
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.039
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.039
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.038
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.038
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.038
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.038
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.038
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.038
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.038
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.038
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.037
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.037
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.037
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.037
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.037
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.036
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.036
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.036
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.036
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.036
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.036
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.035
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.035
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.035
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.035
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.035
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.035
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.035
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.034
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.034
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.034
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.034
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.034
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.034
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.034
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.034
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.034
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.033
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.033
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.033
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.033
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.033
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.033
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.033
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.033
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.032
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.032
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.032
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.032
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.032
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.032
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.032
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.031
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.031
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.031
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.031
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.031
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.031
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.031
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.031
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.031
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.030
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.030
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.030
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.030
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.030
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.030
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.030
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.030
|
|
|
|
hypothalamus development
|
GO:0021854 |
16 |
0.030
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.030
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.029
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.029
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.029
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.029
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.029
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.029
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.029
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.028
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.028
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.028
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.028
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.028
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.028
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.028
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.028
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.027
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.027
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.027
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.027
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.027
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.027
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.027
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.026
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.026
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.026
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.026
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.026
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.026
|
|
|
|
neuromuscular process controlling posture
|
GO:0050884 |
14 |
0.025
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.025
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.025
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.025
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.025
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.025
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.025
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.025
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.024
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.024
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.024
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.024
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.024
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.024
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.024
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.024
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.024
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.024
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.024
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.023
|
Mouse |
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.023
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.023
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.023
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.023
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.023
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.023
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.023
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.023
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.023
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.023
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.023
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.023
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.023
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.022
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.022
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.022
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.022
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.022
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.022
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.022
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.022
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.022
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.022
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.022
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.021
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.021
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.021
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.021
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.021
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.021
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.021
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.021
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.021
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.021
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.021
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.021
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.021
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.020
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.020
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.020
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.020
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.020
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.020
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.020
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.020
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.020
|
Mouse |
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.019
|
|
|
|
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002823 |
23 |
0.019
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.019
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.019
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.019
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.019
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.019
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.019
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.019
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.019
|
|
|
|
regulation of interleukin 12 production
|
GO:0032655 |
30 |
0.019
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.019
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.019
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.019
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.019
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.019
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.019
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.019
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.019
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.019
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.019
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.019
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.018
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.018
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.018
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.018
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.018
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.018
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.018
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.018
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.018
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.018
|
|
|
|
regulation of isoprenoid metabolic process
|
GO:0019747 |
1 |
0.018
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.018
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.018
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.018
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.018
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.018
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.018
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.018
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.018
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.018
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.017
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.017
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.017
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.017
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.017
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.017
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.017
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.017
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.017
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.017
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.017
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.017
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
Mouse |
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.017
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.017
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.016
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.016
|
|
|
|
metanephric thick ascending limb development
|
GO:0072233 |
2 |
0.016
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.016
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.016
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.016
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.016
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.016
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.016
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.016
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.016
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.016
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.016
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.016
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.016
|
|
|
|
interleukin 12 production
|
GO:0032615 |
32 |
0.016
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.016
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.016
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.016
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.016
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.016
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.016
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.016
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.015
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.015
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.015
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.015
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.015
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.015
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.015
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.015
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.015
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.015
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.015
|
Mouse |
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.015
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.015
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.015
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.015
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.015
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.015
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.015
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.015
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.015
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.015
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.015
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.015
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.015
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.015
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.015
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.015
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.015
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.015
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.015
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.015
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.015
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.014
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.014
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.014
|
|
